ECONOMYNEXT – The National Medicine Regulatory Authority (NMRA) in Sri Lanka has approved the emergency use of the Russian made Sputnik V vaccine, State Minister of Production, Supply and Regulation of Pharmaceuticals Channa Jayasumana said.
“This vaccine is produced in the Gamaleya Research Institute of Epidemiology and Microbiology a
Russian medical-research institute which operates under the purview of the Ministry of Health of the Russian Federation,” Jayasumana said.
“We believe within the next few weeks we will be able to bring it to Sri Lanka,” he said.
Russian Direct Investment Fund claims the vaccine to be 95 per cent effective against the Covid 19 virus.
The Vaccine should be stored at temperatures of between 2 and 8C degrees (a standard fridge is roughly 3-5C degrees) and the second jab is required to be taken after 21 days from receiving the first jab.
However, the second dose of the Sputnik V carries a different formula than the first dose.
Both formulas target the Coronavirus’s distinctive ‘spike’, each dose in Sputnik V contains a slightly
different vector – the neutralized virus that carries the spike to the body.
The Vaccines has been approved by 39 countries in the world for emergency use in order to create immunity in the citizens however, the World Health organization is yet to approve the vaccine. (Colombo/ March 21/2021)
Reported by Chanka Jayasinghe